Reply to D.L. Raunig

[1]  D. Raunig.  Are onsite image evaluations the solution or are we trading one problem for another? , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  B. Freidlin,et al.  Blinded independent central review of progression-free survival in phase III clinical trials: important design element or unnecessary expense? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.